Financials

  • Market Capitalization 14.7 M
  • Employee 6
  • Founded 2010
  • CEO N/A
  • Website www.adial.com
  • Headquarter Delaware, United States
  • FIGI BBG00HNGDTR4
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.46
Price to sales ratio
24.52

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4658
NCEL
NewcelX Ltd. - Ordinary Shares
3.19 USD-6.73%-6.18%-8.33%-37.20%15.30 M USD
4660
LSTA
Lisata Therapeutics, Inc. - Common Stock
1.69 USD-7.14%+3.68%+56.48%-25.55%15.23 M USD
4673
PASG
Passage Bio, Inc. - Common Stock
4.52 USD+4.39%-3.00%+0.89%-48.87%14.54 M USD
4688
INTS
Intensity Therapeutics, Inc. - Common Stock
4.25 USD-0.47%-7.00%-1.39%+1417.86%13.88 M USD

Frequently asked questions about Adial Pharmaceuticals, Inc

What is the Adial Pharmaceuticals, Inc stock price today?

The current price of Adial Pharmaceuticals, Inc (ADIL) is 5.60. Over the past 24 hours, the stock has changed by -1.58%. Follow the ADIL chart for real-time price dynamics.

What is the stock ticker of Adial Pharmaceuticals, Inc?

Adial Pharmaceuticals, Inc trades under the ticker ADIL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Adial Pharmaceuticals, Inc stock going up?

ADIL has changed by -9.53% over the last week, +78.91% over the last month, and +1335.90% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Adial Pharmaceuticals, Inc?

Adial Pharmaceuticals, Inc currently has a market capitalization of 14.7 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Adial Pharmaceuticals, Inc earnings last quarter?

Last quarter, Adial Pharmaceuticals, Inc reported earnings of -11.25 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Adial Pharmaceuticals, Inc revenue for the last quarter?

Adial Pharmaceuticals, Inc reported quarterly revenue of -6.05 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Adial Pharmaceuticals, Inc net income for the last quarter?

Adial Pharmaceuticals, Inc reported net income of -51.99 M for the last quarter. The previous quarter showed -2.02 M, which means net income changed by -2470.67%.

How many employees does Adial Pharmaceuticals, Inc have?

As of the latest available data, Adial Pharmaceuticals, Inc has 6 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Adial Pharmaceuticals, Inc stock?

You can buy Adial Pharmaceuticals, Inc (ADIL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Adial Pharmaceuticals, Inc stock?

Investing in Adial Pharmaceuticals, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADIL chart and related analysis on metatrader.com as part of your research.

News